Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.
Samani NJ, Raitakari OT, Sipilä K, Tobin MD, Schunkert H, Juonala M, Braund PS, Erdmann J, Viikari J, Moilanen L, Taittonen L, Jula A, Jokinen E, Laitinen T, Hutri-Kähönen N, Nieminen MS, Kesäniemi YA, Hall AS, Hulkkonen J, Kähönen M, Lehtimäki T. Samani NJ, et al. Among authors: kesaniemi ya. Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1679-83. doi: 10.1161/ATVBAHA.108.170332. Epub 2008 Jul 3. Arterioscler Thromb Vasc Biol. 2008. PMID: 18599798 Free article.
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M. Flavell DM, et al. Among authors: kesaniemi ya. Circulation. 2002 Mar 26;105(12):1440-5. doi: 10.1161/01.cir.0000012145.80593.25. Circulation. 2002. PMID: 11914252
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
Talmud PJ, Martin S, Steiner G, Flavell DM, Whitehouse DB, Nagl S, Jackson R, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Humphries SE, Syvänne M; Diabetes Atherosclerosis Intervention Study Investigators. Talmud PJ, et al. Among authors: kesaniemi ya. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):644-9. doi: 10.1161/01.ATV.0000065196.61663.8D. Epub 2003 Mar 6. Arterioscler Thromb Vasc Biol. 2003. PMID: 12692006 Clinical Trial.
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.
Elrayess MA, Webb KE, Flavell DM, Syvänne M, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Jukema JW, Kastelein JJ, Zwinderman AH, Humphries SE. Elrayess MA, et al. Among authors: kesaniemi ya. Atherosclerosis. 2003 May;168(1):131-8. doi: 10.1016/s0021-9150(03)00089-3. Atherosclerosis. 2003. PMID: 12732396
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events.
Elrayess MA, Webb KE, Bellingan GJ, Whittall RA, Kabir J, Hawe E, Syvänne M, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Miller GJ, Humphries SE. Elrayess MA, et al. Among authors: kesaniemi ya. Atherosclerosis. 2004 Nov;177(1):127-35. doi: 10.1016/j.atherosclerosis.2004.06.009. Atherosclerosis. 2004. PMID: 15488875
375 results